Literature DB >> 1259913

Estimation in sera by radioimmunoassay of a specific membrane antigen associated with a murine lymphoma.

A Wolf, K A Steele, P Alexander.   

Abstract

Material with a molecular weight of less than 10(5) daltons has been isolated and partially purified from the ascitic fluid of DBA2 mice bearing a syngeneic lymphoma (SL2). This substance inhibits the cytotoxic action of an allogeneic antiserum directed specifically against SL2 cells. Material has been rendered radioactive with 125I and between 20 and 25% of the radioactivity is bound in a specific manner to the antiserum. The material which is referred to as 125I-TSTA has been used in a radioimmunoassay to measure the level of TSTA in the sera of mice bearing both ascitic and subcutaneous SL2 tumours. The level of circulating TSTA was found to be high immediatley following inoculation of live SL2 cells, probably because a large proportion of the injected cells autolyse. The serum concentration of TSTA then falls but 6-10 days later begins to rise again in parallel with the growth of the SL2 tumour either in the peritoneal cavity or subcutaneously. Following surgical removal of an intradermal SL2 tumour the level of TSTA in the serum falls rapidly. No evidence could be found that a significant proportion of the TSTA in the serum of tumour-bearing mice is completed with antibody. However, in the serum of DBA2 mice which have been hyperimmunized with irradiated SL2 cells there are antibodies which bind 125I-TSTA although syngeneic anti-SL2 sera, unlike alloantisera, do not show complement dependent lysis of SL2 cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1259913      PMCID: PMC2024929          DOI: 10.1038/bjc.1976.19

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING CR-51-LABELLED TARGET CELLS.

Authors:  H WIGZELL
Journal:  Transplantation       Date:  1965-05       Impact factor: 4.939

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Properties of histocompatibility (HL-A) determinants. II. Soluble antigen-antibody complexes.

Authors:  K I Welsh; A R Sanderson
Journal:  Transplantation       Date:  1974-03       Impact factor: 4.939

4.  Determination of human histocompatibility antigens in the peripheral blood by radioimmunoassay.

Authors:  Y Miyakawa; N Tanigaki; Y Yagi; D Pressman
Journal:  Transplantation       Date:  1972-05       Impact factor: 4.939

5.  Radioimmunoassay and saturation analysis. Preparation and assessment of radioactive tracers.

Authors:  W M Hunter
Journal:  Br Med Bull       Date:  1974-01       Impact factor: 4.291

6.  Radioimmune assay of carcinoembryonic antigen.

Authors:  M L Egan; J T Lautenschleger; J E Coligan; C W Todd
Journal:  Immunochemistry       Date:  1972-03

7.  Xenogeneic recognition of tumour spcific plasma membrane antigens derived from mouse lymphoma cells.

Authors:  A Wolf; R K Barfoot; R A Johnson
Journal:  Immunology       Date:  1972-03       Impact factor: 7.397

8.  Separation of a tumour specific transplantation-type antigen from the ascitic fluid of mice bearing a syngeneic lymphoma.

Authors:  A Wolf; K A Steele
Journal:  Br J Cancer       Date:  1975-06       Impact factor: 7.640

9.  Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers.

Authors:  D M Thomson; V Sellens; S Eccles; P Alexander
Journal:  Br J Cancer       Date:  1973-11       Impact factor: 7.640

  9 in total
  3 in total

1.  Radioiodination of rat hepatoma-specific antigens and retention of serological reactivity.

Authors:  D Hannant; J G Bowen; M R Price; R W Baldwin
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

2.  A serologically detected tumour-specific membrane antigen of murine lymphomas which is not the target for syngeneic graft rejection.

Authors:  G C Davey; G A Currie; P Alexander
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

3.  A tumour-associated antigen from the pleural effusion of patients with squamous-cell carcinoma of lung.

Authors:  A Wolf
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.